Eyenovia’s stock craters to its lowest point in its six-year lifespan as a public company following the biotech’s termination ...

Bluebird has just two quarters until it’s out of cash. Executives are looking for financing to extend that runway to a ...

Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and ...

Trump’s HHS pick, Robert F. Kennedy Jr., is an anti-vaccine campaigner who has previously said that he plans to gut the FDA ...

Gilead’s layoffs include 72 employees at its Seattle location, which will close. Kite will shut down its Philadelphia ...